| Entry |
|
|---|
| Name |
Panazepide (JAN);
Pranazepide;
FK 480;
FR 120480 |
|---|
| Formula |
C26H19FN4O2
|
|---|
| Exact mass |
438.1492
|
|---|
| Mol weight |
438.45
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Efficacy |
Anti-inflammatory, Cholecystokinin receptor antagonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Cholecystokinin
CCKAR
D01858 Panazepide (JAN)
CCKBR
D01858 Panazepide (JAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 33
1 C8y C 27.3295 -6.9374
2 N1y N 28.5737 -6.3044
3 C5x C 29.8521 -6.8765
4 C1y C 30.1977 -8.2230
5 C8y C 27.0544 -8.3192
6 N2x N 29.3608 -9.3486
7 C2y C 27.9599 -9.3874
8 C8y C 26.2771 -6.0141
9 C8x C 24.9513 -6.4639
10 C8x C 24.6762 -7.8458
11 C8x C 25.7286 -8.7690
12 C1x C 28.3562 -4.9255
13 C1x C 26.9775 -4.7063
14 O5x O 30.9111 -5.9828
15 C8y C 27.3872 -10.6705
16 N1b N 31.3824 -8.8900
17 C5a C 32.5949 -8.1900
18 C8y C 33.8073 -8.8900
19 O5a O 32.5949 -6.7902
20 N4x N 33.9537 -10.2826
21 C8y C 35.3234 -10.5737
22 C8y C 36.0235 -9.3611
23 C8x C 35.0865 -8.3205
24 C8x C 36.0234 -11.7862
25 C8x C 37.4234 -11.7862
26 C8x C 38.1235 -10.5735
27 C8x C 37.4235 -9.3611
28 C8x C 25.9872 -10.6705
29 C8x C 25.2872 -11.8829
30 C8x C 25.9872 -13.0953
31 C8x C 27.3872 -13.0953
32 C8y C 28.0872 -11.8829
33 X F 29.4699 -11.8831
BOND 38
1 3 4 1
2 1 5 2
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 2
8 1 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 5 11 1
13 2 12 1
14 12 13 1
15 13 8 1
16 3 14 2
17 7 15 1
18 4 16 1 #Up
19 16 17 1
20 17 18 1
21 17 19 2
22 18 20 1
23 20 21 1
24 21 22 2
25 22 23 1
26 18 23 2
27 21 24 1
28 24 25 2
29 25 26 1
30 26 27 2
31 22 27 1
32 15 28 2
33 28 29 1
34 29 30 2
35 30 31 1
36 31 32 2
37 15 32 1
38 32 33 1
|
|---|
